GAB1 and breast carcinoma: Additionally, cellular localisation of Gab1 and Gab1 variants in naive cells and cells treated with the above-mentioned inhibitors was investigated.<h4>Results</h4>We show that, activation of the Gab1/PI3K/MAPK signalling network is heterogeneous between different breast cancer subtypes.